Cannabis MSO Green Thumb Industries raises $56 million in share sale


Chicago-based multistate cannabis operator Green Thumb Industries raised roughly $56 million from selling shares in the United States.

Green Thumb (GTI) accepted offers to purchase 1.6 million subordinate voting shares for $35.50 per share. The sale is expected to close Feb. 23.

The capital raise follows another funding earlier this month, when GTI sold $100 million worth of stock to an institutional investor in the U.S.

Green Thumb will use the proceeds of the $56 million capital raise “for general corporate purposes, including working capital, operating expenses and capital expenditures,” according to a prospectus filed with the U.S. Securities and Exchange Commission.

“We may also use a portion of the net proceeds to acquire or make investments in businesses, products, offerings and technologies, although we do not have agreements or commitments for any material acquisitions or investments at this time,” GTI noted in the prospectus.

In a news release issued Tuesday, Green Thumb CEO Ben Kovler said investor demand “suggests growing confidence within the U.S. capital markets for cannabis.”

“The Green Thumb team is excited by the momentum and is proactively advocating for U.S. cannabis companies to receive access to U.S. exchanges like our Canadian peers,” he said.

Shares of Green Thumb trade on the U.S. over-the-counter markets as GTBIF and on the Canadian Securities Exchange as GTII.


Source link

Medical Disclaimer:

The information provided in these blog posts is intended for general informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. The use of any information provided in these blog posts is solely at your own risk. The authors and the website do not recommend or endorse any specific products, treatments, or procedures mentioned. Reliance on any information in these blog posts is solely at your own discretion.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like